Anzeige
Erschienen in:
23.11.2015 | Original article
Efficacy and safety of catheter ablation vs. rate control of atrial fibrillation in systolic left ventricular dysfunction
A meta-analysis and systematic review
Erschienen in: Herz | Ausgabe 4/2016
Einloggen, um Zugang zu erhaltenAbstract
Purpose
It is unclear what constitutes the optimal strategy for management of atrial fibrillation (AF) in patients with systolic left ventricular (LV) dysfunction. We hypothesized that catheter ablation of AF had benefits compared with rate control in patients with systolic LV dysfunction.
Methods
PubMed, Embase, and the Cochrane Library were searched for randomized controlled trials and nonrandomized, observational studies. Weighted mean differences (WMD) and 95 % confidence intervals (CIs) were calculated to compare the improvement of left ventricular ejection fraction (LVEF), functional capacity, and quality of life between a catheter ablation group and a rate control group.
Results
Six trials with 324 patients were included in the analysis. Patients in the catheter ablation group had greater improvement of LVEF (WMD: 8.89; 95 % CI: 6.93–10.86; p < 0.001), 6-min walk distance (WMD: 46.9; 95 % CI: 28.5–65.4; p < 0.001), and lower Minnesota Living With Heart Failure Questionnaire (MLHFQ) scores (WMD: − 19.6; 95 % CI: − 23.6–− 15.7; p < 0.001) compared with patients in the rate control group. Overall, there were only ten procedure-related events and the procedure-related events rate was 4.9 % per procedure and 5.6 % per patient.
Conclusion
The present analysis suggests that catheter ablation of AF has benefits in terms of an improvement in LVEF, in functional capacity, and in quality of life compared with rate control in patients with systolic LV dysfunction, and the risk of complications related to procedures is acceptable.